Indian Pharmaceutical Supplier to Peru

Peruvian buyers reach for Indian pharmaceutical supply when the cost gap on a CENARES line is real but DIGEMID’s Spanish-language dossier requirement makes shortcuts impossible. M Care Exports works that exact seam: WHO-GMP medicines and biologicals shipped from Mumbai into Callao and Lima, with CTD dossiers translated into Spanish, CDSCO Certificate of Pharmaceutical Product packs assembled to DIGEMID format, and tender pricing held firm against the PEN/USD line. We service the dual public channel — CENARES national strategic procurement plus EsSalud social-security purchasing — alongside Auna, San Pablo, and the Lima private hospital cluster, plus the Quicorp/Inkafarma/Mifarma retail layer.

WHO-GMP sourcing CDSCO licensed exporter EU-GMP capable partners Cold-chain validated (2–8°C & −25°C) CTD / eCTD dossier-ready ISO 9001:2015
Regulatory environment

DIGEMID, Spanish dossiers, and the CENARES tender clock

Peru’s pharmaceutical regulator is DIGEMID (Dirección General de Medicamentos, Insumos y Drogas), operating under the Ministry of Health (MINSA). DIGEMID accepts CDSCO Certificate of Pharmaceutical Product as the foundational evidence of Indian-origin compliance, alongside WHO-GMP attestation, full CTD dossiers, and stability data on ICH Zone IVa conditions. Dossiers must be filed in Spanish; English source documents are accepted only with sworn translation by an officially recognised translator. We prepare the Spanish dossier package in-house and route the sworn translation step before submission.

Procurement structure runs on three tracks. CENARES (Centro Nacional de Abastecimiento de Recursos Estratégicos en Salud) handles strategic-product national tendering for the public hospital network. EsSalud, the social-security insurer, runs its own procurement cycle for its hospitals and polyclinics. The private side moves through licenced importers feeding the Auna and San Pablo hospital chains and the Quicorp / Inkafarma / Mifarma retail networks — and a meaningful share of those importer shipments originate in India.

The country-specific friction is twofold: Spanish-language dossier preparation drags timelines for suppliers without on-the-ground translation discipline, and CENARES tender cycles run long with award-to-shipment windows that can stretch quarters. Political volatility since 2022 has added to procurement-calendar drift. We price tenders with that drift built in, hold MA validity diaries against DIGEMID renewals, and confirm Spanish artwork rounds before any commercial print run.

Banking is straightforward: PEN is fully convertible, USD invoicing is standard for cross-border pharma, and Peruvian commercial banks clear Indian SWIFT receipts without sanctions overlay. We bill in USD against advance plus shipping documents.

Call & WhatsApp the Mumbai desk: +91 70156 05768 · info@mcareexports.com · Mon–Sat 09:30–18:30 IST

PE
What we do for Peruvian customers

Six lanes we operate on the Peru route

DIGEMID dossier in Spanish, CTD-formatted

We assemble the full CTD dossier in Spanish for DIGEMID submission, with sworn translation routed through a recognised Lima translator. CDSCO Certificate of Pharmaceutical Product is annexed in original plus apostilled form. Stability data is presented on ICH Zone IVa conditions, and artwork is rendered in Spanish with the regulatory text DIGEMID expects on inner and outer packaging.

CENARES tender desk support

CENARES strategic-product tenders demand price discipline across long award windows. We hold quoted prices firm against PEN/USD movement, prepare the technical-documentation pack DIGEMID and CENARES require for sample evaluation, and stage manufacturing to match award-to-delivery windows so a CENARES win does not become an inventory-carry burden for the awardee importer.

EsSalud procurement orientation

EsSalud’s health-network procurement runs on its own cycle, separate from CENARES. We prepare evidence packs sized for EsSalud reviewers — bioequivalence summaries on key generic categories, comparator-product references where mandated, and pharmacovigilance contacts in Lima working hours so that signal-handling does not stall during EsSalud audits.

Lima private-chain importer support

Auna, San Pablo, and the wider private-hospital cluster source through licenced importers who in turn buy direct from origin. We carry those importers as direct counterparties — consolidated multi-product shipments, bilingual COA packs, and Lima-business-hours technical support — so the importer can run formulary additions inside Auna and San Pablo without added overhead.

Cold-chain biologicals into Callao & LIM

Insulin analogues, cold-chain biologicals, and 2–8°C oncology presentations move air via Jorge Chávez International (LIM), with validated qualified containers, dataloggers, and a documented temperature deviation protocol. Sea cold-chain into Callao is reserved for ambient-stable inventory; biologicals stay on the air lane.

Pharmacovigilance and post-market support

DIGEMID expects active pharmacovigilance contact and timely Periodic Safety Update Reports on registered products. We maintain a dedicated PV mailbox, run signal review on Spanish-language adverse-event reports, and file PSURs on the DIGEMID schedule so MA renewals proceed without compliance gaps at the five-year mark.

Mumbai to Lima

Sea via Callao, air via Jorge Chavez

Air freight Mumbai to Lima runs via Doha or São Paulo connections on Qatar Airways Cargo, LATAM Cargo, and Lufthansa Cargo into Jorge Chávez International (LIM). Cold-chain biologicals and high-value oncology presentations move on the air lane; door-to-DIGEMID-bonded-warehouse transit runs eight to eleven days door-to-door, including Lima customs clearance with a CDSCO-credentialed pre-alert. Validated qualified containers carry the 2–8°C cargo with continuous temperature logging.

Sea freight moves Nhava Sheva to Callao via trans-shipment at Singapore or Balboa, on Maersk, MSC, and CMA CGM rotations. Transit runs thirty-five to forty-five days. Callao is the dominant pharma sea entry for Peru and we route ambient-stable generic volumes — anti-infectives, cardiovascular tablets, oral antidiabetics — on this lane to defend landed cost on CENARES tenders. FCL is the working norm for tender awards; LCL is reserved for top-up consignments.

Payment terms run USD against advance plus shipping documents for first orders, migrating to LC-at-sight or extended-credit cycles once the importer relationship matures. PEN is fully convertible against USD, Peruvian commercial banks clear Indian SWIFT receipts cleanly, and there is no sanctions overlay. We invoice ex-Mumbai in USD with itemised landed-cost projection so the importer can model PEN tender pricing with confidence.

ES
Rx
Formulary focus

What Peruvian formularies actually consume

Peruvian demand splits across a public-tender base load that prizes anti-infective and cardiovascular generics at scale, a private-hospital layer in Lima that pulls in oncology and specialty CNS molecules, and a retail-chain layer that consumes broad chronic-care and OTC volumes. The combined picture is a high-volume generics country with a meaningful and growing specialty oncology overlay through Auna and San Pablo.

Top moving categories on our Peru lane are anti-infectives (amoxicillin / clavulanate, ceftriaxone, azithromycin, meropenem), cardiovascular (amlodipine, losartan, atorvastatin, clopidogrel), oncology cytotoxics and targeted therapies (cisplatin, carboplatin, docetaxel, imatinib, capecitabine), oral antidiabetics (metformin, glimepiride, sitagliptin), and respiratory inhalers and nebulisations (salbutamol, budesonide, ipratropium / salbutamol combinations).

The growth area is oncology supportive care and biosimilars: filgrastim, pegfilgrastim, and rituximab biosimilars are entering Peruvian private-hospital formulary at pace, and Indian biosimilar manufacturers are competitive on these molecules. We carry these as priority lines on the Peru lane and keep stability data and comparator references ready for Auna and San Pablo formulary committees.

A Lima-based licenced importer feeding the San Pablo private hospital cluster came to us after a previous origin had stumbled on Spanish artwork compliance — DIGEMID had rejected a batch on inner-foil text rendering, and the importer’s formulary slot was at risk. We rebuilt the artwork pack from scratch in Spanish, ran it through a sworn translator on a forty-eight-hour SLA, and re-submitted with corrected DIGEMID-format text on three SKUs across cardiovascular and anti-infective categories. The corrected batch cleared DIGEMID inner-pack review on first re-submission. We then layered in CENARES tender support on the same molecules, holding USD-denominated pricing firm across a four-month award window. Twelve months on, the importer is running a four-SKU programme on our Mumbai-to-Callao lane, with cold-chain biologicals being qualified next quarter through Jorge Chávez. Illustrative operational case — not a real customer.

Illustrative operational case Peru · Lima licenced importer · cardiovascular and anti-infectives
Why Peru works with us

Built for the DIGEMID-Spanish-CENARES seam

A Peruvian importer or hospital procurement officer choosing an Indian pharmaceutical supplier is making a structural cost-and-compliance trade. The cost case for Indian generics on amlodipine, atorvastatin, ceftriaxone, and oncology cytotoxics is straightforward against European or Latin American origin pricing — the gap on a CENARES tender line can run twenty to forty per cent. The compliance case is harder, because DIGEMID’s Spanish-language dossier requirement and ICH Zone IVa stability evidence punish suppliers who run a generic English pack across all markets without country-specific tailoring.

M Care brings the operating discipline that closes the gap. We run CTD dossiers in Spanish in-house, carry sworn-translation routing as a standard step, hold CDSCO CoPP and WHO-GMP attestations current across our supplier panel, and keep Lima-business-hours technical support on the line for Auna, San Pablo, CENARES, and EsSalud reviewer questions. The result is a Mumbai-to-Callao lane that behaves like a properly localised Peruvian supply lane, not a generic LATAM shipment.

PE
Peru FAQ

What Peruvian buyers most often ask

Which Indian regulatory document does DIGEMID accept as proof of origin compliance?

DIGEMID accepts the CDSCO Certificate of Pharmaceutical Product (CoPP) issued by India’s Central Drugs Standard Control Organization, alongside WHO-GMP attestation for the manufacturing site. The CoPP must be apostilled, dated within validity, and accompanied by the Indian manufacturing licence and a full CTD dossier filed in Spanish. We prepare the apostilled CoPP pack and the full Spanish dossier in-house, and route sworn translation through a Lima-recognised translator before DIGEMID submission, which prevents the document-quality rejections that drag first-time MAs.

Do dossiers really need to be in Spanish, or is English accepted?

DIGEMID requires Spanish-language filing. English source documents are accepted only with sworn translation by an officially recognised translator. In practice, attempting to submit in English with a translator’s note slows review and triggers correction requests. We prepare the dossier directly in Spanish CTD format, treating sworn translation as a standard pre-submission step rather than a post-submission patch. This matters most on inner and outer packaging artwork text, where DIGEMID enforces Spanish rendering tightly and rejects batches at customs on artwork non-compliance.

How does CENARES tendering work for an Indian-origin supplier?

CENARES (Centro Nacional de Abastecimiento de Recursos Estratégicos en Salud) runs strategic-product national tenders for Peru’s public hospital system. Foreign manufacturers do not bid CENARES directly; the awardee is a Peruvian importer or distributor holding the DIGEMID MA and supply chain. We support the importer by holding firm USD pricing across the long award-to-shipment window, supplying the technical-documentation pack CENARES reviewers expect, and staging manufacturing to match the award schedule so the importer is not carrying inventory cost on a delayed lift-up.

What about EsSalud, separate from CENARES?

EsSalud is the social-security health insurer running its own hospital network and polyclinic procurement, separate from MINSA-driven CENARES tendering. EsSalud cycles run on different calendars and demand evidence packs in Spanish — bioequivalence summaries on key generics, comparator-product references where mandated, and pharmacovigilance contact details in Peruvian working hours. We orient our pack to both channels and keep the EsSalud-specific evidence layer ready so an importer can target both public buyers from a single supply relationship.

Which port and airport do you ship through?

Sea volume runs through Callao, the dominant pharma sea entry for Peru, on Maersk, MSC, and CMA CGM rotations from Nhava Sheva via Singapore or Balboa trans-shipment. Air volume runs through Jorge Chávez International (LIM), with Qatar Airways Cargo, LATAM Cargo, and Lufthansa Cargo as the working carriers via Doha or São Paulo. Cold-chain biologicals and high-value oncology stay on the air lane in validated qualified containers; ambient generics ride sea to defend landed cost on CENARES tender pricing.

Are there sanctions or banking constraints on India-Peru pharma trade?

No. Peru is a fully convertible-currency, sanctions-clean banking jurisdiction. PEN clears against USD without restriction, USD invoicing is standard practice in cross-border pharma, and Peruvian commercial banks — BCP, BBVA Perú, Interbank, Scotiabank Perú — receive Indian SWIFT remittances cleanly. We invoice ex-Mumbai in USD, work to LC-at-sight or advance-plus-documents on early shipments, and migrate to extended-credit cycles once the importer relationship is established.

Can M Care help register oncology biosimilars with DIGEMID?

Yes. Indian biosimilar manufacturing on filgrastim, pegfilgrastim, rituximab, and trastuzumab is competitive against European origin and is entering Peruvian private-hospital formulary through Auna and San Pablo. DIGEMID treats biosimilars under a comparability-evidence framework requiring head-to-head clinical and analytical data against the reference product. We assemble the biosimilar dossier in Spanish, annex CDSCO biological-product clearances, and stage cold-chain validation runs into Jorge Chávez ahead of first commercial shipment.

Indian pharmaceutical supply built for Peru

From Mumbai to Lima with DIGEMID-grade discipline

Spanish dossier, in-house

Full CTD in Spanish, sworn translation routed through a recognised Lima translator, CDSCO CoPP apostilled, artwork rendered to DIGEMID-format Spanish text on inner and outer pack.

CENARES + EsSalud dual orientation

Tender-pricing discipline for CENARES strategic-product cycles and an evidence pack tuned to EsSalud reviewers, so a single supply relationship covers both Peruvian public-procurement channels.

Callao sea + LIM air, split by stability

Ambient generics ride Callao sea on Maersk, MSC, and CMA CGM. Cold-chain biologicals and oncology fly Jorge Chávez via Qatar Airways Cargo, LATAM Cargo, and Lufthansa Cargo in qualified containers.

Shop by therapeutic area

Top categories we ship to Peru

Start a Peru shipment

Send the SKU list. We come back with a Lima-ready quote.

Send your SKU list, target volumes, and the channel you are filling — CENARES tender, EsSalud cycle, Auna or San Pablo private formulary, or retail-chain supply through Quicorp, Inkafarma, or Mifarma. We come back inside two working days with a USD landed-cost projection, a DIGEMID dossier-readiness note in Spanish, and a Mumbai-to-Callao or Mumbai-to-LIM transit plan against your award window.

Start a Peru enquiry Back to all markets